BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Palatini P, De Martin S. Pharmacokinetic drug interactions in liver disease: An update. World J Gastroenterol 2016; 22(3): 1260-1278 [PMID: 26811663 DOI: 10.3748/wjg.v22.i3.1260]
URL: https://www.wjgnet.com/1007-9327/full/v22/i3/1260.htm
Number Citing Articles
1
Subrahmanyam Vangala, Uday Saxena, C. Satish Chandran. Microfluidics and Multi Organs on Chip2022; : 695 doi: 10.1007/978-981-19-1379-2_29
2
Eman El‐Khateeb, Adam S. Darwich, Brahim Achour, Varinder Athwal, Amin Rostami‐Hodjegan. Review article: time to revisit Child‐Pugh score as the basis for predicting drug clearance in hepatic impairmentAlimentary Pharmacology & Therapeutics 2021; 54(4): 388 doi: 10.1111/apt.16489
3
Juveriya Farooq, M.M. Sana, P.M. Chetana, Mansour Almuqbil, Nagapati Prabhakar Bhat, Rokeya Sultana, UmaimaFarheen Khaiser, Syed Mohammed Basheeruddin Asdaq, Mutlaq Eidhah M. Almalki, Amro Mohammed sawadi Khormi, Salem Ahmad Albraiki, Moneer E. Almadani. Polypharmacy in chronic liver disease patients: Implications for disease severity, drug-drug interaction, and quality of lifeSaudi Pharmaceutical Journal 2023; 31(8): 101668 doi: 10.1016/j.jsps.2023.06.001
4
Lianne J. Stevens, Joanne M. Donkers, Jeroen Dubbeld, Wouter H. J. Vaes, Catherijne A. J. Knibbe, Ian P. J. Alwayn, Evita van de Steeg. Towards human ex vivo organ perfusion models to elucidate drug pharmacokinetics in health and disease Drug Metabolism Reviews 2020; 52(3): 438 doi: 10.1080/03602532.2020.1772280
5
Maddi Srinivas. Cytochrome P450 Enzymes, Drug Transporters and their Role in Pharmacokinetic Drug-Drug Interactions of Xenobiotics: A Comprehensive ReviewOpen Journal of Chemistry 2017; : 001 doi: 10.17352/ojc.000006
6
Kelly M. Mahar, Bonnie C. Shaddinger, Bandi Ramanjineyulu, Susan Andrews, Stephen Caltabiano, Alistair C. Lindsay, Alexander R. Cobitz. Pharmacokinetics of Daprodustat and Metabolites in Individuals with Normal and Impaired Hepatic FunctionClinical Pharmacology in Drug Development 2022; 11(5): 562 doi: 10.1002/cpdd.1090
7
Marija Jovanović, Milena Kovačević, Sandra Vezmar-Kovačević, Ivan Palibrk, Jasna Bjelanović, Branislava Miljković, Katarina Vučićević. Lidocaine clearance as pharmacokinetic parameter of metabolic hepatic activity in patients with impaired liverJournal of Medical Biochemistry 2023; 42(2): 304 doi: 10.5937/jomb0-38952
8
Michael D. Wiese, Ashley S. Meakin, Tamara J. Varcoe, Jack R.T. Darby, Ousseynou Sarr, Patti Kiser, Emma L. Bradshaw, Timothy R.H. Regnault, Janna L. Morrison. Hepatic cytochrome P450 function is reduced by life-long Western diet consumption in guinea pig independent of birth weightLife Sciences 2021; 287: 120133 doi: 10.1016/j.lfs.2021.120133
9
Xiao-nan Gao, Xu-yang Nie, Jing-lin Gao, Tian-fang Heng, Yu-qi Zhang, Li Hua, Ya-qi Sun, Zhang-ying Feng, Ming-xia Wang, Li Jia. Pharmacokinetic Study of Nalbuphine in Surgical Patients Undergoing General Anesthesia with Varying Degrees of Liver DysfunctionDrug Design, Development and Therapy 2022; : 2383 doi: 10.2147/DDDT.S371596
10
Sara Armani, Andreas Geier, Thomas Forst, Uta Merle, David H. Alpers, Martin W. Lunnon. Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug–drug interactionsBritish Journal of Clinical Pharmacology 2024;  doi: 10.1111/bcp.15990
11
Nagaraj M. Kulkarni, Sandeep Malampati, Mahamad Yunnus A. Mahat, S. Chandrasekaran, J. Raghul, Ansar Ali Khan, Uma Maheswari Krishnan, Shridhar Narayanan. Altered pharmacokinetics of rosiglitazone in a mouse model of non-alcoholic fatty liver diseaseDrug Metabolism and Personalized Therapy 2016; 31(3): 165 doi: 10.1515/dmpt-2016-0008
12
Venkatesh Pilla Reddy, Khanh Bui, Graeme Scarfe, Diansong Zhou, Maria Learoyd. Physiologically Based Pharmacokinetic Modeling for Olaparib Dosing Recommendations: Bridging Formulations, Drug Interactions, and Patient PopulationsClinical Pharmacology & Therapeutics 2019; 105(1): 229 doi: 10.1002/cpt.1103
13
Daniela Gabbia, Arianna Dalla Pozza, Laura Albertoni, Roberta Lazzari, Giorgia Zigiotto, Maria Carrara, Vincenzo Baldo, Tatjana Baldovin, Annarosa Floreani, Sara De Martin. Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in early- and late-stage cholestasisWorld Journal of Gastroenterology 2017; 23(42): 7519-7530 doi: 10.3748/wjg.v23.i42.7519
14
Nikolaos Spernovasilis, Diamantis Kofteridis. Pre-Existing Liver Disease and Toxicity of AntifungalsJournal of Fungi 2018; 4(4): 133 doi: 10.3390/jof4040133
15
Heidemarie Kletzl, Hassan Ajmi, Izabela Antys, Katja Heinig, Birgit Jaber, Thomas C. Marbury, Annie Young, Andreas Günther. Effect of mild or moderate hepatic impairment on the pharmacokinetics of risdiplamBritish Journal of Clinical Pharmacology 2022; 88(8): 3749 doi: 10.1111/bcp.15319
16
Flavia Storelli, Caroline Samer, Jean-Luc Reny, Jules Desmeules, Youssef Daali. Complex Drug–Drug–Gene–Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical PerspectivesClinical Pharmacokinetics 2018; 57(10): 1267 doi: 10.1007/s40262-018-0650-9
17
Ying‐Jung Wu, Ching‐Hui Huang, Tusty‐Jiuan Hsieh, Wei‐Lung Tseng, Chi‐Yu Lu. Identification of significant protein markers by mass spectrometry after co‐treatment of cells with different drugs: An in vitro survey platformRapid Communications in Mass Spectrometry 2020; 34(S1) doi: 10.1002/rcm.8582
18
Ira M. Jacobson, Fred Poordad, Roberto Firpi-Morell, Gregory T. Everson, Elizabeth C. Verna, Sanhita Bhanja, Peggy Hwang, Luzelena Caro, Michael Robertson, Edgar D. Charles, Heather Platt. Elbasvir/Grazoprevir in People With Hepatitis C Genotype 1 Infection and Child-Pugh Class B Cirrhosis: The C-SALT StudyClinical and Translational Gastroenterology 2019; 10(4): e00007 doi: 10.14309/ctg.0000000000000007
19
Nicolas Cottura, Hannah Kinvig, Sandra Grañana‐Castillo, Adam Wood, Marco Siccardi. Drug–Drug Interactions in People Living With HIV at Risk of Hepatic and Renal Impairment: Current Status and Future PerspectivesThe Journal of Clinical Pharmacology 2022; 62(7): 835 doi: 10.1002/jcph.2025
20
Tao Wang, Fan Zhang, Xiaotong Wang, Xizhi Li, Hongwei Ling, Dongmei Lv, Xiaoxing Yin, Qian Lu. Predictive factors associated with glycaemic response to exenatide in Chinese patients with type 2 diabetes mellitusJournal of Clinical Pharmacy and Therapeutics 2020; 45(5): 1050 doi: 10.1111/jcpt.13134
21
Lakshmi Viswanathan, Eric Bachman, Simon Tian, Neil Ahluwalia, Yaohua Zhang, Harold S. Bernstein, Paul Panorchan. Phase 1 Study to Assess the Safety and Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Subjects Without Cystic Fibrosis With Moderate Hepatic ImpairmentEuropean Journal of Drug Metabolism and Pharmacokinetics 2022; 47(6): 817 doi: 10.1007/s13318-022-00791-8
22
Yogendra Pal, Pran Kishore Deb, Shantanu Bandopadhyay, Nabamita Bandyopadhyay, Rakesh K. Tekade. Dosage Form Design Considerations2018; : 85 doi: 10.1016/B978-0-12-814423-7.00003-4
23
Sanjita Paudel, Hyoje Jo, Taeho Lee, Sangkyu Lee. Selective inhibitory effects of suberosin on CYP1A2 in human liver microsomesBiopharmaceutics & Drug Disposition 2023; 44(5): 365 doi: 10.1002/bdd.2370
24
Kevin N. Woodward. Regulatory Toxicology in the European Union2018; : 243 doi: 10.1039/9781782622222-00243
25
Takumi Kawanishi, Hiroshi Arakawa, Yusuke Masuo, Noritaka Nakamichi, Yukio Kato. Bile Duct Obstruction Leads to Increased Intestinal Expression of Breast Cancer Resistance Protein With Reduced Gastrointestinal Absorption of ImatinibJournal of Pharmaceutical Sciences 2019; 108(9): 3130 doi: 10.1016/j.xphs.2019.05.017
26
William Cruz, Huang Huang, Brian Barber, Elisa Pasini, Lili Ding, Gang Zheng, Juan Chen, Mamatha Bhat. Lipoprotein‐Like Nanoparticle Carrying Small Interfering RNA Against Spalt‐Like Transcription Factor 4 Effectively Targets Hepatocellular Carcinoma Cells and Decreases Tumor BurdenHepatology Communications 2020; 4(5): 769 doi: 10.1002/hep4.1493
27
Eyad Gadour, Ahmed Kotb. Systematic Review of Antifungal-Induced Acute Liver FailureCureus 2021;  doi: 10.7759/cureus.18940
28
Dong Dong, Hua Sun, Zhufeng Wu, Baojian Wu, Yunxia Xue, Zhijie Li. A validated ultra-performance liquid chromatography-tandem mass spectrometry method to identify the pharmacokinetics of SR8278 in normal and streptozotocin-induced diabetic ratsJournal of Chromatography B 2016; 1020: 142 doi: 10.1016/j.jchromb.2016.03.033
29
David M. Hensler, Deepika P. McConnell, Kimberly E. Levasseur-Franklin, Kasey M. Greathouse. Pentobarbital Removal During Continuous Venovenous Hemofiltration: Case Report and Review of the LiteratureJournal of Pharmacy Practice 2018; 31(6): 682 doi: 10.1177/0897190017743130
30
Eman El-Khateeb, Brahim Achour, Zubida M. Al-Majdoub, Jill Barber, Amin Rostami-Hodjegan. Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage AdjustmentMolecular Pharmaceutics 2021; 18(9): 3563 doi: 10.1021/acs.molpharmaceut.1c00462
31
Andrew H. Talal, Charles S. Venuto, Islam Younis. Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use TreatmentClinical Pharmacology in Drug Development 2017; 6(2): 206 doi: 10.1002/cpdd.336
32
Jongkwon Park, Yun Jung Heo, Soonjo Kwon. Interaction Between Hepatocytes and Proximal Tubular Epithelial Cells in Hypoxia-induced LipotoxicityBiotechnology and Bioprocess Engineering 2022; 27(1): 30 doi: 10.1007/s12257-021-0137-7
33
Kathryn M. Musgrave, Kieron Power, Mike Laffan, James S. O’Donnell, Jecko Thachil, Anthony Maraveyas. Practical treatment guidance for cancer-associated thrombosis – Managing the challenging patient: A consensus statementCritical Reviews in Oncology/Hematology 2022; 171: 103599 doi: 10.1016/j.critrevonc.2022.103599
34
Kazuya Maeda, Akihiro Hisaka, Kiyomi Ito, Yoshiyuki Ohno, Akihiro Ishiguro, Reiko Sato, Naomi Nagai. Classification of drugs for evaluating drug interaction in drug development and clinical managementDrug Metabolism and Pharmacokinetics 2021; 41: 100414 doi: 10.1016/j.dmpk.2021.100414
35
Jean-Luc Szpakowski, Lue-Yen Tucker, David M Baer, Mary Pat Pauly. Hepatotoxicity during legacy cancer chemotherapy in patients infected with hepatitis C virus: A retrospective cohort studyCanadian Liver Journal 2022; 5(1): 43 doi: 10.3138/canlivj-2021-0018
36
Zhenyan Yu, Xiaohan Hu, Lin Zhou, Huliang Chen, Yanchao Xing, Chunyue Han, Hui Ding, Lifeng Han, Guixiang Pan, Zhifei Fu. Studies on Chemical Characterization of Ginkgo Amillaria Oral Solution and Its Drug–Drug Interaction With Piceatannol 3′-O-β-D-Glucopyranoside for InjectionFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.932646
37
Sheng Huang, Renhan Dong, Gaojie Xu, Jin Liu, Xiaofang Gao, Siqi Yu, Pengfan Qie, Gang Gou, Min Hu, Yu Wang, Jian Peng, Bing Guang, Ying Xu, Tai Yang. Synthesis, Characterization, and In Vivo Evaluation of Desmethyl Anethole Trithione Phosphate Prodrug for Ameliorating Cerebral Ischemia-Reperfusion Injury in RatsACS Omega 2020; 5(9): 4595 doi: 10.1021/acsomega.9b04129
38
Paola Infante, Alessio Malfanti, Deborah Quaglio, Silvia Balducci, Sara De Martin, Francesca Bufalieri, Francesca Mastrotto, Irene Basili, Mariangela Garofalo, Ludovica Lospinoso Severini, Mattia Mori, Isabella Manni, Marta Moretti, Carmine Nicoletti, Giulia Piaggio, Paolo Caliceti, Bruno Botta, Francesca Ghirga, Stefano Salmaso, Lucia Di Marcotullio. Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastomaCancer Letters 2021; 499: 220 doi: 10.1016/j.canlet.2020.11.028
39
Antonio Corona, Mary Dominguez, Serife Eti. Palliative Care in Kidney and Liver DiseasesAdvances in Kidney Disease and Health 2023; 30(4): 387 doi: 10.1053/j.akdh.2023.07.003
40
Rosemary T. Smith, Staci A. Gruber. Contemplating cannabis? The complex relationship between cannabinoids and hepatic metabolism resulting in the potential for drug-drug interactionsFrontiers in Psychiatry 2023; 13 doi: 10.3389/fpsyt.2022.1055481
41
Russell R. Kempker, Wael A. Alghamdi, Mohammad H. Al-Shaer, Gena Burch, Charles A. Peloquin. A Pharmacology Perspective on Simultaneous Tuberculosis and Hepatitis C TreatmentAntimicrobial Agents and Chemotherapy 2019; 63(12) doi: 10.1128/AAC.01215-19
42
Carmen Kirchner, Jasmin Sibai, Elke Schwier, Dietrich Henzler, Claas Eickmeyer, Günther Winde, Thomas Köhler. Dosing of Antimycotic Treatment in Sepsis–Induced Liver Dysfunction by Functional Liver Testing with LiMAx®Case Reports in Critical Care 2019; 2019: 1 doi: 10.1155/2019/5362514
43
Charles S. Venuto, Andrew H. Talal. Intrahepatic Sampling for the Elucidation of Antiviral Clinical PharmacologyClinical Pharmacology in Drug Development 2017; 6(2): 169 doi: 10.1002/cpdd.311
44
Weihang Li, Ziyi Ding, Dong Wang, Chengfei Li, Yikai Pan, Yingjing Zhao, Hongzhe Zhao, Tianxing Lu, Rui Xu, Shilei Zhang, Bin Yuan, Yunlong Zhao, Yanjiang Yin, Yuan Gao, Jing Li, Ming Yan. Ten-gene signature reveals the significance of clinical prognosis and immuno-correlation of osteosarcoma and study on novel skeleton inhibitors regarding MMP9Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02041-4
45
Moying Li, Timo Itzel, Nathally Espinosa Montagut, Thomas Falconer, Jimmy Daza, Jimyung Park, Jae Youn Cheong, Rae Woong Park, Isabella Wiest, Matthias Philip Ebert, George Hripcsak, Andreas Teufel. Impact of concomitant cardiovascular medications on overall survival in patients with liver cirrhosisScandinavian Journal of Gastroenterology 2023; 58(12): 1505 doi: 10.1080/00365521.2023.2239974
46
Akifumi Kurata, Takafumi Yoshida, Megumi Inoue, Tomoko Ishizuka, Takafumi Nakatsu, Takako Shimizu, Manabu Kato, Yasuhiro Nishikawa, Hitoshi Ishizuka. Pharmacokinetics and Safety of Single-Dose Esaxerenone in Japanese Subjects with Mild to Moderate Hepatic ImpairmentAdvances in Therapy 2020; 37(1): 253 doi: 10.1007/s12325-019-01121-2
47
Wondim Ayenew, Getahun Asmamaw, Arebu Issa. Prevalence of potential drug-drug interactions and associated factors among outpatients and inpatients in Ethiopian hospitals: a systematic review and meta-analysis of observational studiesBMC Pharmacology and Toxicology 2020; 21(1) doi: 10.1186/s40360-020-00441-2
48
Kehua Zhou, Christos Fountzilas. Outcomes and Quality of Life of Systemic Therapy in Advanced Hepatocellular CarcinomaCancers 2019; 11(6): 861 doi: 10.3390/cancers11060861
49
Elza Sundhani, Agung Endro Nugroho, Arief Nurrochmad, Ika Puspitasari, Dita Amalia Prihati, Endang Lukitaningsih. Pharmacokinetic Herb-Drug Interactions of Glipizide with Andrographis paniculata (Burm. f.) and Andrographolide in Normal and Diabetic Rats by Validated HPLC MethodMolecules 2022; 27(20): 6901 doi: 10.3390/molecules27206901
50
Noor Safwah Damanhuri, Endang Kumolosasi, Marhanis Salihah Omar, Amirul Faiz Abd Razak, Ahmad Hasnan Mansor. The influence of P-glycoprotein expression in the standard treatment of Helicobacter pylori infection in Sprague Dawley ratsDARU Journal of Pharmaceutical Sciences 2021; 29(1): 13 doi: 10.1007/s40199-020-00377-2
51
Sivacharan Kollipara, Tausif Ahmed, Sivadasu Praveen. Physiologically based pharmacokinetic modeling (PBPK) to predict drug-drug interactions for encorafenib. Part II. Prospective predictions in hepatic and renal impaired populations with clinical inhibitors and inducersXenobiotica 2023; 53(5): 339 doi: 10.1080/00498254.2023.2246153
52
EMRE KARA, Kamer Tecen-Yücel, Nesligül Özdemir, Ahmet Çağkan İnkaya, Aygin Bayraktar-Ekincioğlu, Kutay Demirkan, Serhat Ünal. Yoğun Bakım Hastalarında Antibiyotiklerin Diğer İlaçlarla Etkileşimlerinin DeğerlendirilmesiSTED / Sürekli Tıp Eğitimi Dergisi 2019; : 404 doi: 10.17942/sted.599700
53
Martyn Howard, Jill Barber, Naved Alizai, Amin Rostami-Hodjegan. Dose adjustment in orphan disease populations: the quest to fulfill the requirements of physiologically based pharmacokineticsExpert Opinion on Drug Metabolism & Toxicology 2018; 14(12): 1315 doi: 10.1080/17425255.2018.1546288
54
Josefina Gómez-Garduño, Renato León-Rodríguez, Radamés Alemón-Medina, Beatriz E. Pérez-Guillé, Rosa E. Soriano-Rosales, Ailema González-Ortiz, Juan L. Chávez-Pacheco, Edelmira Solorio-López, Paola Fernandez-Pérez, Liliana Rivera-Espinosa. Phytochemicals That Interfere With Drug Metabolism and Transport, Modifying Plasma Concentration in Humans and AnimalsDose-Response 2022; 20(3): 155932582211204 doi: 10.1177/15593258221120485
55
Fadi Rassam, Pim B. Olthof, Bart R. Takkenberg, Ulrich Beuers, Heinz-Josef Klümpen, Roelof J. Bennink, Krijn P. van Lienden, Marc G. Besselink, Olivier R. Busch, Joanne Verheij, Thomas M. van Gulik. Scintigraphic liver function and transient elastography in the assessment of patients with resectable hepatocellular carcinomaHPB 2019; 21(5): 626 doi: 10.1016/j.hpb.2018.09.021
56
Christian Rolfo, Nicolas Isambert, Antoine Italiano, L. Rhoda Molife, Jan H.M. Schellens, Jean‐Yves Blay, Thomas Decaens, Rebecca Kristeleit, Olivier Rosmorduc, Regina Demlova, Myung‐Ah Lee, Alain Ravaud, Katerina Kopeckova, Maria Learoyd, Wendy Bannister, Gershon Locker, Judith de Vos‐Geelen. Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairmentBritish Journal of Clinical Pharmacology 2020; 86(9): 1807 doi: 10.1111/bcp.14283
57
Chun Sing Lam, Rong Hua, Phillip Lung Wai Au-Doung, Yu Kang Wu, Ho Kee Koon, Keary Rui Zhou, Herbert Ho-Fung Loong, Vincent Chi-Ho Chung, Yin Ting Cheung. Association between potential supplement–drug interactions and liver diseases in patients with cancer: A large prospective cohort studyClinical Nutrition ESPEN 2023; 58: 152 doi: 10.1016/j.clnesp.2023.09.919
58
Khalid Alshaghdali, Talal Alharazi, Raja Rezgui, Tolgahan Acar, Raed Fahad Aljerwan, Ahmed Altayyar, Munazzah Tasleem, Mohd Saeed, Dharmendra Kumar Yadav, Amir Saeed. Identification and evaluation of putative type 2 diabetes mellitus inhibitors derived from Cichorium intybusJournal of Molecular Structure 2024; 1306: 137629 doi: 10.1016/j.molstruc.2024.137629